Advances of Fibroblast Growth Factor/Receptor Signaling Pathway in Hepatocellular Carcinoma and its Pharmacotherapeutic Targets
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Advances of Fibroblast Growth Factor/Receptor Signaling Pathway in Hepatocellular Carcinoma and its Pharmacotherapeutic Targets
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-04-16
DOI
10.3389/fphar.2021.650388
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Enhanced chondrogenic phenotype of primary bovine articular chondrocytes in Fibrin-Hyaluronan hydrogel by multi-axial mechanical loading and FGF18
- (2020) Bernardo P. Antunes et al. Acta Biomaterialia
- Fibroblast growth factor (FGF)-21 based therapies: A magic bullet for nonalcoholic fatty liver disease (NAFLD)?
- (2020) Michael Ritchie et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Relation of fibroblast growth factor receptor 2 expression to hepatocellular carcinoma recurrence after liver resection
- (2020) Baek Gyu Jun et al. PLoS One
- Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
- (2020) Ghassan K Abou-Alfa et al. LANCET ONCOLOGY
- Benefit from pemigatinib in cholangiocarcinoma
- (2020) Diana Romero Nature Reviews Clinical Oncology
- Klotho-beta and fibroblast growth factor 19 expression correlates with early recurrence of resectable hepatocellular carcinoma
- (2019) Zhong-Zhe Lin et al. LIVER INTERNATIONAL
- Effect of Fibroblast Growth Factor-2 and its Receptor Gene Polymorphisms on the Survival of Patients With Hepatitis B Virus-associated Hepatocellular Carcinoma
- (2019) SOON SUN KIM et al. ANTICANCER RESEARCH
- GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis
- (2019) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- Rotational Freedom, Steric Hindrance, and Protein Dynamics Explain BLU554 Selectivity for the Hinge Cysteine of FGFR4
- (2019) Xiaojing Lin et al. ACS Medicinal Chemistry Letters
- Discovery and Validation of Novel Biomarkers for Detection of Epithelial Ovarian Cancer
- (2019) Kulbe et al. Cells
- Targeting the Oncogenic FGF-FGFR Axis in Gastric Carcinogenesis
- (2019) Jinglin Zhang et al. Cells
- FGF19–FGFR4 Signaling in Hepatocellular Carcinoma
- (2019) Aroosha Raja et al. Cells
- The role of the fibroblast growth factor family in bone‐related diseases
- (2019) Jicheng Wang et al. Chemical Biology & Drug Design
- FGF401, a first-in-class highly selective and potent FGFR4 inhibitor for the treatment of FGF19-driven hepatocellular cancer
- (2019) Andreas Weiss et al. MOLECULAR CANCER THERAPEUTICS
- First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant Fibroblast Growth Factor 19 Signaling as a Driver Event in Hepatocellular Carcinoma
- (2019) Richard D Kim et al. Cancer Discovery
- Acquired On-Target Clinical Resistance Validates FGFR4 as a Driver of Hepatocellular Carcinoma
- (2019) Megan A. Hatlen et al. Cancer Discovery
- Expression of FGF8, FGF18, and FGFR4 in Gastroesophageal Adenocarcinomas
- (2019) Jomrich et al. Cells
- Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma
- (2019) Takahiro Maeda et al. BMC CANCER
- Vitamin D sterols increase FGF23 expression by stimulating osteoblast and osteocyte maturation in CKD bone
- (2019) Renata C. Pereira et al. BONE
- FGFR2-BICC1: A Subtype Of FGFR2 Oncogenic Fusion Variant In Cholangiocarcinoma And The Response To Sorafenib
- (2019) Xihui Ying et al. OncoTargets and Therapy
- Identification of a FGF18-expressing alveolar myofibroblast that is developmentally cleared during alveologenesis
- (2019) Andrew S. Hagan et al. DEVELOPMENT
- Tumour evolution in hepatocellular carcinoma
- (2019) Amanda J. Craig et al. Nature Reviews Gastroenterology & Hepatology
- Precision Oncology for Hepatocellular Cancer: Slivering the Liver by FGF19–FGFR4–KLB Pathway Inhibition
- (2019) Vivek Subbiah et al. Cancer Discovery
- Up-regulation of FGF15/19 signaling promotes hepatocellular carcinoma in the background of fatty liver
- (2018) Guozhen Cui et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Long non-coding RNA FGFR3-AS1 promotes hepatocellular carcinoma carcinogenesis via modulating PI3K/AKT pathway
- (2018) Juhua Zhuang et al. ONCOLOGY RESEARCH
- Deficiency of fibroblast growth factor 21 (FGF21) promotes hepatocellular carcinoma (HCC) in mice on a long term obesogenic diet
- (2018) Garima Singhal et al. Molecular Metabolism
- Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity
- (2018) Archita Agrawal et al. Molecular Metabolism
- Characterization of Hepatocellular Carcinoma Patients with FGF19 Amplification Assessed by Fluorescence in situ Hybridization: A Large Cohort Study
- (2018) Hyo Jeong Kang et al. Liver Cancer
- Structural Alterations in Human Fibroblast Growth Factor Receptors in Carcinogenesis
- (2018) D. S. Mikhaylenko et al. BIOCHEMISTRY-MOSCOW
- Lenvatinib as a therapy for unresectable hepatocellular carcinoma
- (2018) Andrea Spallanzani et al. Expert Review of Anticancer Therapy
- FGF18, a prominent player in FGF signaling, promotes gastric tumorigenesis through autocrine manner and is negatively regulated by miR-590-5p
- (2018) Jinglin Zhang et al. ONCOGENE
- Hyperprogressive Disease in Patients With Advanced Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy
- (2018) Roberto Ferrara et al. JAMA Oncology
- Fibroblast Growth Factor Receptor 4 (FGFR4) Selective Inhibitors as Hepatocellular Carcinoma Therapy: Advances and Prospects
- (2018) Xiaoyun Lu et al. JOURNAL OF MEDICINAL CHEMISTRY
- A novel 12-marker panel of cancer-associated fibroblasts involved in progression of hepatocellular carcinoma
- (2018) Baojia Zou et al. Cancer Management and Research
- Tivantinib for the treatment of hepatocellular carcinoma
- (2017) Jan Best et al. EXPERT OPINION ON PHARMACOTHERAPY
- FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib
- (2017) Lixia Gao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- (2017) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- Ribosomal protein S15a promotes tumor angiogenesis via enhancing Wnt/β-catenin-induced FGF18 expression in hepatocellular carcinoma
- (2017) Pengyi Guo et al. ONCOGENE
- Inhibition of the growth of hepatocellular carcinoma cells through fibroblast growth factor 18 suppressed by miR-139
- (2017) Li Yang et al. ONCOLOGY REPORTS
- Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis
- (2017) Mei Zhou et al. Nature Communications
- Multiplexed gene expression profiling identifies the FGFR4 pathway as a novel biomarker in intrahepatic cholangiocarcinoma
- (2017) Changhoon Yoo et al. Oncotarget
- Diverse Changes of Circulating Fibroblast Growth Factor 21 Levels in Hepatitis B Virus-Related Diseases
- (2017) Liang Wu et al. Scientific Reports
- Fibroblast growth factor 21 (FGF21) is robustly induced by ethanol and has a protective role in ethanol associated liver injury
- (2017) Bhavna N. Desai et al. Molecular Metabolism
- Biliary cancer: Utility of next-generation sequencing for clinical management
- (2016) Milind Javle et al. CANCER
- Phenotypic and Signaling Consequences of a Novel Aberrantly Spliced Transcript FGF Receptor-3 in Hepatocellular Carcinoma
- (2016) Ke Li et al. CANCER RESEARCH
- Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1
- (2016) Stéphane Champiat et al. CLINICAL CANCER RESEARCH
- A combined series of Fgf9 and Fgf18 mutant alleles identifies unique and redundant roles in skeletal development
- (2016) Irene H. Hung et al. DEVELOPMENTAL BIOLOGY
- Endometrial Cancer-Associated FGF18 Expression Is Reduced by Bazedoxifene in Human Endometrial Stromal Cells In Vitro and in Murine Endometrium
- (2016) Clare A. Flannery et al. ENDOCRINOLOGY
- Mechanistic target of rapamycin complex 1 is an essential mediator of metabolic and mitogenic effects of fibroblast growth factor 19 in hepatoma cells
- (2016) Zhi Yi Wan et al. HEPATOLOGY
- FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review)
- (2016) MASARU KATOH INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- FGFR3 promotes angiogenesis-dependent metastasis of hepatocellular carcinoma via facilitating MCP-1-mediated vascular formation
- (2016) Xinyu Liu et al. MEDICAL ONCOLOGY
- Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise
- (2016) Supriya K. Saha et al. ONCOLOGIST
- KLBis associated with alcohol drinking, and its gene product β-Klotho is necessary for FGF21 regulation of alcohol preference
- (2016) Gunter Schumann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Up-regulation of fibroblast growth factor 19 and its receptor associates with progression from fatty liver to hepatocellular carcinoma
- (2016) Yan Li et al. Oncotarget
- Circulating Fibroblast Growth Factor 21 Is A Sensitive Biomarker for Severe Ischemia/reperfusion Injury in Patients with Liver Transplantation
- (2016) Dewei Ye et al. Scientific Reports
- Expression of functional recombinant human fibroblast growth factor 8b and its protective effects on MPP+-lesioned PC12 cells
- (2015) Nazi Chen et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Molecular Targeted Therapy for Hepatocellular Carcinoma: Present Status and Future Directions
- (2015) Kyung-Ju Choi et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Targeting FGFR Signaling in Cancer
- (2015) M. Touat et al. CLINICAL CANCER RESEARCH
- Fibroblast Growth Factor Signaling Controls Liver Size in Mice With Humanized Livers
- (2015) Willscott E. Naugler et al. GASTROENTEROLOGY
- Fibroblast growth factor receptor 3 isoforms: Novel therapeutic targets for hepatocellular carcinoma?
- (2015) Jakob Paur et al. HEPATOLOGY
- MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma
- (2015) Feng Fang et al. JOURNAL OF HEPATOLOGY
- Erratum: Advances in targeted therapies for hepatocellular carcinoma in the genomic era
- (2015) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- FGF18 as a potential biomarker in serous and mucinous ovarian tumors
- (2015) Saba El-Gendi et al. TUMOR BIOLOGY
- Polymorphisms of FGFR1 in HBV-related hepatocellular carcinoma
- (2015) Haiyang Xie et al. TUMOR BIOLOGY
- First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway
- (2015) M. Hagel et al. Cancer Discovery
- Genomic characterization of a large panel of patient-derived hepatocellular carcinoma xenograft tumor models for preclinical development
- (2015) Qingyang Gu et al. Oncotarget
- FGF19 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells by modulating the GSK3β/β- catenin signaling cascade via FGFR4 activation
- (2015) Huakan Zhao et al. Oncotarget
- The Fibroblast Growth Factor signaling pathway
- (2015) David M. Ornitz et al. Wiley Interdisciplinary Reviews-Developmental Biology
- Fibroblast Growth Factor Receptor 4 Polymorphism Is Associated with Liver Cirrhosis in Hepatocarcinoma
- (2015) Ming-Jen Sheu et al. PLoS One
- FGF8 promotes colorectal cancer growth and metastasis by activating YAP1
- (2015) Rui Liu et al. Oncotarget
- Fibroblast Growth Factor-5 Participates in the Progression of Hepatic Fibrosis
- (2014) Hiromi Hanaka et al. EXPERIMENTAL ANIMALS
- Targeting fibroblast growth factor 19 in liver disease: a potential biomarker and therapeutic target
- (2014) Wen-Yue Liu et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1α-mediated antioxidant capacity in mice
- (2014) Dewei Ye et al. HEPATOLOGY
- Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development
- (2014) Iker Uriarte et al. INTERNATIONAL JOURNAL OF CANCER
- A preclinical evaluation of a novel multikinase inhibitor, SKLB-329, as a therapeutic agent against hepatocellular carcinoma
- (2014) Lei Zhong et al. INTERNATIONAL JOURNAL OF CANCER
- Targeted inhibition of the FGF19-FGFR4 pathway in hepatocellular carcinoma; translational safety considerations
- (2014) Howard R. Mellor LIVER INTERNATIONAL
- Autocrine fibroblast growth factor 18 signaling mediates Wnt-dependent stimulation of CD44-positive human colorectal adenoma cells
- (2014) Inga Koneczny et al. MOLECULAR CARCINOGENESIS
- Downregulation of microRNA-214 and overexpression of FGFR-1 contribute to hepatocellular carcinoma metastasis
- (2013) Jian Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Activation of Liver FGF21 in hepatocarcinogenesis and during hepatic stress
- (2013) Chaofeng Yang et al. BMC GASTROENTEROLOGY
- MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma
- (2013) Hao Yang et al. HEPATOLOGY
- Fibroblast growth factor signaling in liver carcinogenesis
- (2013) Dalbir S. Sandhu et al. HEPATOLOGY
- A short story of Klotho and FGF23: a deuce of dark side or the savior?
- (2013) F. Fevzi Ersoy INTERNATIONAL UROLOGY AND NEPHROLOGY
- FGF Receptors: Cancer Biology and Therapeutics
- (2013) Masaru Katoh et al. MEDICINAL RESEARCH REVIEWS
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Clinical Trials in Hepatocellular Carcinoma: An Update
- (2013) Ying-Chun Shen et al. Liver Cancer
- Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma
- (2012) Seiki Miura et al. BMC CANCER
- βKlotho Is Required for Fibroblast Growth Factor 21 Effects on Growth and Metabolism
- (2012) Xunshan Ding et al. Cell Metabolism
- Targeting Fibroblast Growth Factor Receptor Signaling in Hepatocellular Carcinoma
- (2012) Ann-Lii Cheng et al. ONCOLOGY
- Differential Specificity of Endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in Complex with KLB
- (2012) Chaofeng Yang et al. PLoS One
- Targeting FGFR4 Inhibits Hepatocellular Carcinoma in Preclinical Mouse Models
- (2012) Dorothy M. French et al. PLoS One
- Regulation of Amphiregulin Gene Expression by β-Catenin Signaling in Human Hepatocellular Carcinoma Cells: A Novel Crosstalk between FGF19 and the EGFR System
- (2012) Maria U. Latasa et al. PLoS One
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Emerging Signaling Pathways in Hepatocellular Carcinoma
- (2012) Agrin Moeini et al. Liver Cancer
- Identification of a Therapeutic Strategy Targeting Amplified FGF19 in Liver Cancer by Oncogenomic Screening
- (2011) Eric T. Sawey et al. CANCER CELL
- Connective tissue growth factor autocriny in human hepatocellular carcinoma: Oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein-mediated activation
- (2011) Raquel Urtasun et al. HEPATOLOGY
- Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease
- (2011) N. Itoh et al. JOURNAL OF BIOCHEMISTRY
- Association between fibroblast growth factor receptor 4 polymorphisms and risk of hepatocellular carcinoma
- (2011) Yuan Yang et al. MOLECULAR CARCINOGENESIS
- Reduced Expression of Fibroblast Growth Factor Receptor 2IIIb in Hepatocellular Carcinoma Induces a More Aggressive Growth
- (2010) Thomas Amann et al. AMERICAN JOURNAL OF PATHOLOGY
- Extending the family table: Insights from beyond vertebrates into the regulation of embryonic development by FGFs
- (2010) Sarah Tulin et al. BIRTH DEFECTS RESEARCH PART C-EMBRYO TODAY-REVIEWS
- Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease
- (2010) Nobuyuki Itoh CELL AND TISSUE RESEARCH
- Up-regulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesis
- (2010) Christine Gauglhofer et al. HEPATOLOGY
- Research Resource: Comprehensive Expression Atlas of the Fibroblast Growth Factor System in Adult Mouse
- (2010) Klementina Fon Tacer et al. MOLECULAR ENDOCRINOLOGY
- The Significance of Fibroblast Growth Factor Receptor 2 Expression in Differentiation of Hepatocellular Carcinoma
- (2010) Norifumi Harimoto et al. ONCOLOGY
- Fibroblast Growth Factors: Biology, Function, and Application for Tissue Regeneration
- (2010) Ye-Rang Yun et al. Journal of Tissue Engineering
- Amphiregulin Induces the Alternative Splicing of p73 Into Its Oncogenic Isoform ΔEx2p73 in Human Hepatocellular Tumors
- (2009) Josefa Castillo et al. GASTROENTEROLOGY
- Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway
- (2009) Edoardo Missiaglia et al. JOURNAL OF CLINICAL ONCOLOGY
- The FGF family: biology, pathophysiology and therapy
- (2009) Andrew Beenken et al. NATURE REVIEWS DRUG DISCOVERY
- New cellular tools reveal complex epithelial–mesenchymal interactions in hepatocarcinogenesis
- (2008) S Sagmeister et al. BRITISH JOURNAL OF CANCER
- Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention
- (2008) Han Kiat Ho et al. JOURNAL OF HEPATOLOGY
- FGF-21/FGF-21 receptor interaction and activation is determined by βKlotho
- (2007) Alexei Kharitonenkov et al. JOURNAL OF CELLULAR PHYSIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now